We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 914

Starbucks Puts Another False Advertising Lawsuit On Ice
  • Reed Smith LLP
  • USA
  • October 18 2016

On Friday, the U.S. District Court for the Northern District of Illinois dismissed a class-action lawsuit against Starbucks. The class alleged a


Expert Who Admitted That He Was Unqualified and That His Opinions Lacked Methodology Not Allowed to Testify in Zoloft Litigation.
  • Reed Smith LLP
  • USA
  • October 24 2016

Last week, the Drug and Device Law Lifelong BFF asked us if we were interested in a quick trip to New York to use tickets for an early morning taping


FDA releases drugdevice industry social media guidance documents
  • Reed Smith LLP
  • USA
  • June 23 2014

The FDA released two draft social media guidance documents last week, describing how manufacturers, packers and distributors of prescription drugs


On the ball in the old dominion
  • Reed Smith LLP
  • USA
  • August 16 2013

There are several reasons we recommend taking a look at last week's decision in Ball v. Takeda Pharmaceuticals America, Inc., 2013 WL 4040395 (E.D


A stale roll and a dismal clean sweep
  • Reed Smith LLP
  • USA
  • April 24 2013

People usually think it's a good thing to be "on a roll." But that is not always the case. We have defended client depositions where there was


Dicta gone wild on generic preemption
  • Reed Smith LLP
  • USA
  • May 1 2014

We talk about preemption so often that we can be hesitant to post on preemption cases unless we can see that they offer something new or different


Federal appeals court rejects False Claims Act Suit based on drug packaging cGMP violations
  • Reed Smith LLP
  • USA
  • February 26 2014

Last Friday, the U.S. Court of Appeals for the Fourth Circuit affirmed the dismissal of a False Claims Act ("FCA") case brought against Omnicare.1


Statistics not necessary for adequacy as a matter of law
  • Reed Smith LLP
  • USA
  • November 13 2014

Courtesy of Mike Imbroscio of Covington (who was on the winning team) today's post is about a very satisfying Cymbalta win - not only did warning


A walk atround primary jurisdiction
  • Reed Smith LLP
  • USA
  • June 19 2013

You might not know it from the Comments section of our blog, but we get lots of interesting reader mail. While the Comments often seem confined to


Play it again: the limits of collateral estoppel
  • Reed Smith LLP
  • USA
  • August 7 2013

You all will recall the following hypothetical from law school: a train wreck occurs in which 50 passengers are injured. If the first plaintiff sues